OUHSC Research News – Monday, November 14, 2022

 

Notices and Reminders

Guidance for Collecting Demographic Diversity Data via Survey

In 2019 the National Institutes of Health (NIH) released the “Notice of NIH's Interest in Diversity” that identified populations that should be prioritized to ensure national scientific workforce diversity goals are achieved. To achieve this aim, identified offices on campus, including the Offices of Diversity, Equity, and Inclusion (DEI) and Institutional Research (IR), collaborate to understand the diversity attributes (ethnicity, disadvantaged status, disability status, etc.) of HSC faculty, staff, and students. These activities inform a number of functions including institutional planning, decision-making, and external reporting efforts. Reports on these data attributes are often included as a component of required annual reporting, as an example, or may be considered necessary in certain applications. In many cases, these data are available from the University already and need not be surveyed again. Prior to conducting your survey, please confirm with the DEI and IR offices to see if the data you need, or reliable proxy measures, are already available.

Survey Guidelines:

In cases where data collection is necessary, please adhere to the following guidelines to ensure your data collection activities result in valid, complete, and properly aggregated data:

• Include procedures to maintain the anonymity and confidentiality of survey respondents.
• Make clear to survey recipients that their participation is voluntary and they are free to not participate.
• Ensure that responses cannot be traced back to respondents.
• Ensure that no personally identifiable information is captured.

Exclusions:

• Survey instruments that are a component of an Institutional Review Board (IRB) approved research study don’t require further review.

If your survey instrument does not meet the exclusion criterion but you believe it needs to collect identifiable information, please contact the office of DEI at Diversity-Inclusion@ouhsc.edu.

You will be contacted to discuss your request and clarify the specific information you need. Please allow at least 3 business days for the completion of your request.

 

Workshops and Seminars

Free Workshop - IDeA National Resource for Quantitative Proteomics

On December 6, 2022, the Oklahoma INBRE and IDeA National Resource for Quantitative Proteomics are hosting a workshop describing the different proteomics methods available in the National Resource. One goal of the National Resource is to make advanced proteomics methods available to all Oklahoma scientists. Mike Kinter’s OMRF laboratory is a part of the resource along with Alan Tackett’s group at the University of Arkansas for Medical Sciences. The workshop will take place in the Conference Center at the Oklahoma Medical Research Foundation (OMRF). All Oklahoma scientists are invited. The workshop is free and includes lunch, but space is limited.

Registration is required but is done simply by emailing mike-kinter@omrf.org. The deadline is Wednesday November 30. A flyer for the workshop is attached.

 

17^th Annual Pediatric Research Day

Date: Friday, January 20, 2023

Venue: Samis Education Center

Deadline for abstract submission: Wednesday, November 16, 2022

Description: Pediatric Research Day, Sponsored by Children’s Health Foundation, highlights various types of research, case reports, advocacy and QI projects informing on neonatal/adolescent development, pediatric care, and pathogenesis/treatment of pediatric diseases to showcase medical and graduate trainees, share mutual interests, and initiate collaborative ideas. Individuals outside the Department of Pediatrics are highly encouraged to participate. Contact Jeffrey-Eckert@ouhsc.edu or Ashley-Baker@ouhsc.edu should you have any questions or need clarification.

Link to the event page: Pediatrics Research Day

 

Bioinformatics and Computational Biology Mini-Symposium

Breakout Sessions on Special Topics

To Foster Interdisciplinary Research and Education in Bioinformatics and Computational Biology between Engineering, Science, and Medicine

Day/Time: November 18, 2022 (FRIDAY); 9:00 AM To 4:30 PM

Venue: Forum Building, OU, Norman

Description: A mini-symposium is being planned at the OU-Norman campus to bring together Bioinformatics and Computational Biology researchers from both the OU-Norman and OUHSC campuses. This mini-symposium aims to establish collaborations between OUHSC researchers performing Omics analyses with bioinformatics researchers at OU-Norman so that together we can build a highly skilled workforce for Omics data analyses, including single-cell RNA sequencing and spatial transcriptomics. At the symposium, we will highlight current work in the single-cell Omics field at OUHSC and provide an overview of how high-end computational approaches to Omics could further biomedical research projects on both campuses. Overall, we aim to foster collaboration in research and education, increase the understanding of state-of-the-art Omics tools and techniques, and explore avenues for increasing our bioinformatics and computationally skilled workforce to support Bioinformatics/Computational Biology analyses on the OUHSC and OU-Norman campuses. If you are currently performing Omics research, plan to perform Omics research, or are interested in learning about Omics research, please click on the link below to register. Lunch and refreshments will be provided.

TO REGISTER: https://ousurvey.qualtrics.com/jfe/form/SV_ehABtbxZyjcAm6G

Schedule:

9am: Introduction and welcome

9:15am – 12 noon: Short 20 minutes talks on biological applications of omics.

12-1:15pm: Lunch/keynote speaker.

1:30-3: Breakout sessions:

• Talent Development for the Omics World!

• AI development for omics

• Funding opportunities [public, private, foundation]

3:00 – 4:30: Possible Poster Sessions

Website: https://ou.edu/coe/resources/industry/bcbsymposium#multitask

 

2022 END2CANCER

Registration Deadline: November 27, 2022

Description: OU Health Stephenson Cancer Center is proud to host the 2022 END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer conference from December 1-2, 2022 in Oklahoma City, Oklahoma, USA.
The END2CANCER conference will start the morning of December 1, 2022 and conclude in the afternoon of December 2, 2022. The conference will bridge laboratory research conducted in the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis, imaging and treatment of cancer. The conference will host keynote, plenary and invited lectures by eminent scientists who will discuss new and emerging concepts, technologies and challenges in translating nanomedicine from bench-to-bedside.
Topics to be discussed in the planned thematic sessions include Gene and Drug Delivery, Immuno-Oncology, Drug Discovery and New Drugs on the Horizon for Clinical Translation, Extracellular Vesicles, Combinatorial Therapeutics, and more to come. 
The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers, physicists, chemists, post-doctoral fellows, high-school and college students, patient advocates, business professionals, educators and technology transfer specialists. Students and fellows will have an opportunity to present their work and compete for cash awards. We will again be hosting a special session titled "Art of Science in Light of Nanomedicine" will allow participants to display their best research as a photo with a caption and compete for a cash prize.

We will be hosting a reception and dinner at the Devon Boathouse on Dec. 1 from 6:30 to 9:30 p.m.
Please RSVP by Nov. 22 if you wish to attend: https://ousurvey.qualtrics.com/jfe/form/SV_07HhnSZxanlky3A

Registration: https://ousurvey.qualtrics.com/jfe/form/SV_00nwMfqywKeREW2

 

The National Symposium on Sexual Behavior of Youth Call for Poster Abstracts

Description: Join your colleagues on Wednesday, February 22, 2023 from 5:00p - 7:00p for the multi-disciplinary NSSBY poster session that will highlight the latest research, programs, and activities in the field.  Light snacks will be available during the poster session, which will be concurrent with the Welcome Reception.  The poster session provides opportunities for extended discussion with symposium participants about your work.
Poster submissions must be received by November 30, 2022.  Announcements of acceptance will be made by December 15, 2022.  
Posters describing innovative programs and implementation strategies are encouraged and welcomed.  Posters can focus on a wide variety of topics related to the sexual behavior of youth, such as:

• sexual development
• sex education
• healthy sexual behavior
• impact of technology
• problematic/harmful and/or illegal sexual behavior
• assessment
• treatment
• long-term outcomes

More information can be found at: https://connect.ncsby.org/nssby2023/call-for-proposals/posters

Questions? OU-NCSBY@ouhsc.edu

 

OUHSC Funding Opportunities

Call for Applications: PHF Equipment, Symposium, and Seed Grant Programs

Grant Type	Deadline
Equipment	November 30, 2022
Symposium	November 30, 2022
Seed	December 2, 2022

 

 

 

 

 

 

 

Presbyterian Health Foundation (PHF) Equipment Grant Program – Request For Applications

• Cycle I PHF Equipment Grant Program Deadline: November 30, 2022

The primary objective of the PHF Equipment Grant program is to provide partial funding for critically needed research equipment. Funding priority will be given to research equipment that will permit OUHSC investigators to be more competitive for external funding and provides support to multiple users. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) All Assistant, Associate, or Full Professors are eligible to apply.; 2) Principal investigators with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes, such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Requests should be sent to ORA4PHF@ouhsc.edu.; 3) PHF Equipment Grant recipients may hold any other PHF Grant award simultaneously, except for a Clinician Scientist Development Award. 

 

Presbyterian Health Foundation (PHF) Symposium Grant Program – Request For Applications

• Cycle I PHF Symposium Grant Program Deadline: November 30, 2022

The primary objective of the PHF Symposium Grant program is to provide partial funding to support a National or International Symposium to be held at the OUHSC campus or in Oklahoma City. Funding priority will be given to themes that will promote research already present at OUHSC and OMRF and include both OUHSC faculty members and OMRF members in the Organization Committee. OUHSC Principal Investigators are eligible to apply if they meet the following criteria: 1) The Principal Investigator of the application must be the Chair of the Organizing Committee. Only OUHSC full-time, tenure-track faculty members (unmodified titles) are eligible to be PIs. 2). The PI may hold any other PHF Grant award, except for a Clinician Scientist Development Award.

Presbyterian Health Foundation (PHF) Seed Grant Program – Request For Applications

• Cycle I PHF Seed Grant Program Deadline: December 2, 2022

The primary objective of the PHF Seed Grant program is to provide a one-year grant for new OUHSC investigators to initiate research programs. Secondary objectives are to provide established OUHSC faculty with the opportunity to initiate new unfunded projects and to provide unfunded OUHSC faculty funds to initiate a research program. Applications from new investigators (within 5 years of first full academic appointment and never having received independent federal funds) are given special consideration during peer review and at the time of funding consideration. Principal Investigators with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Approval will require a letter from their Department Chairperson indicating a departmental commitment of salary, research space, and time for development of an independent career at OUHSC.  Requests should be sent to ORA4PHF@ouhsc.edu PHF Seed Grant recipients may not hold a PHF Bridge Grant or a PHF Clinician Scientist Development Grant during the duration of this award.

IMPORTANT UPDATE: This PHF Seed Grant program can now provide funding for up to $75,000 for one year. SALARY and FRINGE BENEFITS may be requested for the Principal Investigator(s) up to $25,000 in total (salary + fringe benefits = $25,000) with the remaining portion, $50,000, used to support the project costs.

Guidelines and Application Forms are attached or can be found at https://research.ouhsc.edu/research-administration/grants/funding-opportunities/phf-funding. If you have any questions, please email VPR@ouhsc.edu.

 

Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

• A world-leader in vaccine manufacturing is seeking research linking viral or bacterial infection and chronic disorders in order to develop new treatments targeting microbial pathogens. In scope: biological approaches to prevent or reduce chronic disease, research relating to any chronic condition, provided there is a validated link with bacterial or viral infection.  Out of scope: small molecule, enzyme therapy, gene therapy and cell therapy.  Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 12/22).
• Johnson Matthey is seeking research proposals to develop metal trapping materials for use in fluid catalytic cracking (FCC).  Of particular interest are materials with highly efficient/stable trapping for iron and vanadium under high temperatures and steam and functional and deactivation mechanism of metal trapping materials under FCC conditions.  Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 12/22).

 

American Cancer Society Institutional Research Grant (ACS-IRG)               

DEADLINE: Friday, December 16, 2022; Due by 5:00 PM

ACS-IRG funds provide $50,000 to new/early stage faculty with cancer research pilot projects

Eligibility Criteria:

• ASSISTANT PROFESSOR or equivalent level position that holds a tenure- or research-track appointment on OUHSC, OU-Norman or OU-Tulsa campus and within SIX years of first independent academic appointment.
• Without CURRENT grant support from national funding agencies (e.g. NIH, DOD, NSF, ACS).

INSTRUCTIONS AND APPLICATION:

Application, Guidelines and more information can be found:

Application, Forms & Guidelines | SCC Website

For questions, please contact The SCC Office of Cancer Research                                 

CancerResearch@ouhsc.edu

 

ASSISTANT PROFESSOR FACULTY POSITIONS: Cellular and Molecular GeroScience CoBRE

The Center for Geroscience and Healthy Brain Aging at the University of Oklahoma Health Sciences Center (OUHSC) invites exceptional scientists to apply for tenure-track eligible faculty positions. Applications from individuals with expertise in multiple research areas related to the biology of aging or to diseases associated with aging are requested. Areas of special interest include but are not limited to bioenergetics, metabolism, adult stem cells/tissue regeneration, cell signaling and mechanisms of neurodegeneration.  The individual(s) selected will be appointed as Assistant Professor in a Basic Science Department at OUHSC and will join the NIA P20 Cellular and Molecular Geroscience CoBRE Program, from which they will receive substantial research funding while they apply for independent NIH funds. The start date will be during the Spring/Summer of 2023 at dates negotiated with successful applicants. 

Minimum Qualifications and Requirements: Successful candidates are expected to develop innovative and externally funded research programs, participate in education programs, and contribute to university service. Candidates should have a PhD and/or MD and are expected to have significant postdoctoral research experience with the potential of developing a nationally recognized research program.  The individuals should have Early Stage Investigator (ESI) status and not been awarded an independent NIH grant.

The Center for Geroscience and Healthy Brain Aging is a highly interactive group of scientists with interests in aging, brain aging, neurological diseases of aging, gero-oncology, developmental determinants of aging, metabolism, diabetes, and immunology. The Center for Geroscience is home to the NIA P30 Oklahoma Nathan Shock Center on Aging, the NIA T32 Geroscience Training Program and the NIA P20 Cellular and Molecular Geroscience CoBRE grant and receives over $10M in extramural funding annually.  Successful applicants will receive a competitive salary, a multi-year start-up package, and be assigned newly renovated laboratory space.

Candidates should submit a Specific Aims page, an NIH Biosketch and a ½ page list of Future Directions  as a single pdf file.  Contact information for at least three references should be included.  Please send the application packet to Melissa-K-Day@ouhsc.edu  no later than Monday, December 12^th, 2022. The applicant is expected to write a full CoBRE application that will be part of the Phase 2 CoBRE renewal due May 25, 2023, with the assistance of the leadership of the Center for Geroscience.

The University of Oklahoma and the Center for Geroscience have a commitment to diversity, equality, and inclusion. The University of Oklahoma Health Sciences Center is an equal employment opportunity and affirmative action institution http://www.ou.edu/eoo. Individuals with disabilities and protected veterans are encouraged to apply.

 

NIH Notices 

• Notice of Informational Webinar for the NIGMS Postbaccalaureate Research Education Program (PREP) (R25)
  (NOT-GM-23-021)
• Request for Information (RFI): Developing Strategies to Strengthen Research on Stillbirth Prevention
  (NOT-HD-22-054)
• Notice of Change to Award Information in PAR-21-258, NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
  (NOT-AI-23-004)
• Notice of Participation of NIDA in NOT-ES-22-006, "Notice of Special Interest (NOSI): Climate Change and Health"
  (NOT-DA-22-065)
• Notice to Extend Expiration Date for NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
  (NOT-DE-23-003)
• Notice to update Section III - Eligibility Information for RFA-FD-23-004-Centers of Excellence in Regulatory Science and Innovation (CERSI) (U01) Clinical Trials Optional
  (NOT-FD-23-001)
• Notice of Need to Expire and Reissue PAR-22-107-Centers Of Excellence In Genomic Science (RM1 Clinical Trial Optional) To Clarify Review Criteria For The Resource Sharing Plan
  (NOT-HG-23-012)
• Notice of Change to Key Dates and Review Locus for RFA-NS-19-043 BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
  (NOT-NS-23-039)
• Notice of Change to Key Dates and Review Locus for RFA-NS-19-044 "BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required)"
  (NOT-NS-23-040)
• Notice of Change: Advanced Training in Artificial Intelligence for Precision Nutrition Science Research (AIPrN) Institutional Research Training Programs (T32)
  (NOT-OD-23-020)
• Notice of Intent to Publish a Funding Opportunity Announcement for Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
  (NOT-GM-23-017)
• Notice of Special Interest (NOSI): Chemoproteomic Approaches for Discovery of Targets and Therapeutics to Treat Substance Use Disorders
  (NOT-DA-24-005)
• Notice of Special Interest (NOSI): Advancing Research in Lipoprotein(a) and Cardiovascular Disease (R01 Clinical Trials Allowed) and (R01 No Clinical Trials Allowed)
  (NOT-HL-22-052)
• Notice of Special Interest (NOSI): Explainable Artificial Intelligence for Decoding and Modulating Neural Circuit Activity Linked to Behavior
  (NOT-MH-23-110)

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH Funding Opportunities

• Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed)
  (PAR-23-046)
  Application Receipt Date(s): January 07, 2026
• Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)
  (PAR-23-047)
  Application Receipt Date(s): January 07, 2026
• Transformative Educational Advancement and Mentoring Network (TEAM) (R25 Clinical Trial Not Allowed)
  (RFA-CA-23-013)
  Application Receipt Date(s): February 10, 2023
• Investigating the Effects of Addictive Substances on Brain Developmental Trajectories Using Innovative Scalable Methods for Quantification of Cell Identity, Lineage and Connectivity (R01 - Clinical Trial Not Allowed)
  (RFA-DA-23-036)
  Application Receipt Date(s): February 02, 2023
• Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Not Allowed
  (RFA-FD-23-009)
  Application Receipt Date(s): January 16, 2023
• John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed)
  (RFA-MD-22-010)
  Application Receipt Date(s): January 17, 2023
• Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
  (RFA-OD-22-023)
  Application Receipt Date(s): Multiple dates, see announcement.
• Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)
  (RFA-OD-22-024)
  Application Receipt Date(s): Multiple dates, see announcement.
• Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
  (RFA-OD-22-025)
  Application Receipt Date(s): Multiple dates, see announcement.
• Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required )
  (RFA-OD-22-026)
  Application Receipt Date(s): Multiple dates, see announcement.
• Miner Safety and Health Training Program - Western United States
  (RFA-OH-23-004)
  Application Receipt Date(s): February 19, 2023

 

Other Funding Opportunities

Cystic Fibrosis Foundation Call for Mental Health Research Working Group Members

Description: The mission of the Cystic Fibrosis Mental Health Research Working Group (MHRWG) is to advance our knowledge of mental health conditions in the CF population throughout the lifespan and promote clinical and translational research that will improve the understanding, prevention, diagnosis, and treatment of mental health concerns in CF. The MHRWG is seeking to create a multi-disciplinary group, including, but not limited to, physicians/psychiatrists, psychologists/neuropsychologists, social workers, pharmacists etc., and other specialists with an interest in CF mental health. Applications must be submitted online at awards.cff.org. For questions, please contact Dara Riva (driva@cff.org) and Kayli Davis (kaydavis@cff.org).

Applications Due: December 14, 2022

Link to Full Announcement: https://www.cff.org/researchers/mental-health-research-working-group

 

Cystic Fibrosis Foundation Medical Resident Research Award

Description: The newly launched CF Foundation Medical Resident Research Award is designed to introduce residents to research through participation in a CF-relevant research project with the goal to develop and maintain interest in a career in CF research or as a CF care provider. Awards support up to $10,000 in salary or research related costs for one year and applications are accepted on a rolling basis at awards.cff.org. For questions, please contact Liz Yu (eyu@cff.org).

Link to Full Announcement: https://www.cff.org/researchers/medical-resident-research-award

 

Call for Pre-Proposals Early K99/R00 Funding Opportunity Announcements

NCI just reissued so-called “early K99/R00” - NCI Pathway to Independence Award for Outstanding Early-Stage Postdoctoral Researchers Funding Opportunity Announcements (FOAs).

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-035.html

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-036.html

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-037.html

This Early K99/R00 award in many respects, such as duration, financial support, etc. is similar to the parent K99/R00. However, there are several important differences:

• Only postdoctoral (or postdoc-like) researchers with less than 2 years of postdoctoral research experience by the submission due date (February 28, 2023) are eligible to apply
• Each candidate must be nominated by the institution and a nomination letter (2 pgs max) must be included in the application (refer to the FOAs for the requirements)
• Each institution may submit up to 3 applications, but each application must be in a different field of science: one in data science, one in cancer control science and one in other sciences. Please refer to the FOAs for the field of science definition
• Early K99/R00 applications are reviewed by a special emphasis panel, therefore, they are not competing with the regular/parent K99/R00.
  • Preliminary data are not required
  • Publication with the current/postdoctoral mentor are not required

Pre-proposal is due to Stevie Warner by November 18, 2022. The Education, Training, and Career Enhancement Core will organize a review committee and select an applicant from each field of science to nominate for submission. This selection and notifications will take place by December 2, 2022 to allow the selected candidates ample time to write their full application.

• Specific Aims page
• Biosketch
• Letter of Support from Mentor

Application Due Date: Submissions must be received by February 28, 2023 at 5:00 PM local time of applicant organization.

 

The Leona M. and Harry B. Helmsley Charitable Trust’s (Helmsley) Type 1 Diabetes (T1D) Program

Description: The Leona M. and Harry B. Helmsley Charitable Trust’s (Helmsley) Type 1 Diabetes (T1D) Program is launching a Request for Proposals (RFP) to support the development of novel, real-world solutions to help people with T1D exercise safely and to improve their quality of life. Researchers and clinicians are expected to partner with statistical teams to analyze the real-world data that was collected under Helmsley’s T1D Exercise Initiative (T1-DEXI), build collaborations with other necessary third parties, and to test their novel solutions in studies with people with T1D. The overarching purpose of this initiative is to move real-world data towards real-world solutions.

Concept Notes due: April 30, 2023

Link to Full Announcement: https://helmsleytrust.org/request_for_proposal/improving-exercise-with-type-1-diabetes-moving-data-towards-solutions/

 

Cystic Fibrosis Foundation Idea Development Award

Description: The Spring 2023 Idea Development Award (IDA) is intended to support work that leads to sufficient project development to enable an application for future research funding from the Cystic Fibrosis Foundation or the National Institutes of Health. For more information, visit the IDA webpage.  For questions, please contact Dara Riva (driva@cff.org).

Applications Due: February 2, 2023

Link to Full Announcement: https://www.cff.org/researchers/idea-development-award